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Abstract
Background: Loss of dignity for people with advanced cancer is associated with high levels of
psychological and spiritual distress and the loss of the will to live. Dignity Therapy is a brief psychotherapy,
which has been developed to help promote dignity and reduce distress. It comprises a recorded interview,
which is transcribed, edited then returned to the patient, who can bequeath it to people of their choosing.
Piloting in Canada, Australia and the USA, has suggested that Dignity Therapy is beneficial to people with
advanced cancer and their families. The aims of this study are to assess the feasibility, acceptability and
potential effectiveness of Dignity Therapy to reduce psychological and spiritual distress in people with
advanced cancer who have been referred to hospital-based palliative care teams in the UK, and to pilot
the methods for a Phase III RCT.
Design: A randomised controlled open-label trial. Forty patients with advanced cancer are randomly
allocated to one of two groups: (i) Intervention (Dignity Therapy offered in addition to any standard care),
and (ii) Control group (standard care). Recipients of the 'generativity' documents are asked their views on
taking part in the study and the therapy. Both quantitative and qualitative outcomes are assessed in face-
to-face interviews at baseline and at approximately one and four weeks after the intervention (equivalent
in the control group). The primary outcome is patients' sense of dignity (potential effectiveness) assessed
by the Patient Dignity Inventory. Secondary outcomes for patients include distress, hopefulness and quality
of life. In view of the relatively small sample size, quantitative analyses are mainly descriptive. The
qualitative analysis uses the Framework method.
Discussion: Dignity Therapy is brief, can be delivered at the bedside and may help both patients and their
families. This detailed exploratory research shows if it is feasible to offer Dignity Therapy to patients with
advanced cancer, many of whom are likely to be in the terminal stage of their illness, whether it is
acceptable to them and their families, if it is likely to be effective, and determine whether a Phase III RCT
is desirable.
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There has been much progress in the assessment and treat-
ment of the somatic symptoms of people with advanced
cancer, however less is known about assessing and treat-
ing psychosocial, existential and spiritual issues. Loss of
dignity for people with advanced cancer is associated with
high levels of psychological and spiritual distress and the
loss of the will to live[1]. For some people, a sense that
nothing of one's life will be transcendent of death was
associated with loss of dignity, and many felt that main-
taining dignity was highly dependent on how they per-
ceived themselves to be seen by others. It is therefore
crucial to develop and evaluate interventions to address
these needs. An empirically based model of dignity in the
terminally ill has been developed in Canada from inter-
views with 50 people with advanced cancer focussing on
what supports and what undermines their dignity [2,3].
The model comprises three major categories (illness-
related concerns, dignity conserving repertoire, social
aspects of the illness experience), which refer to broad
issues that determine how individuals experience a sense
of dignity as death approaches. Each of the three catego-
ries has several themes and sub-themes. The model pro-
vides a theoretical framework, which helps understanding
of how people with advanced cancer may experience a
loss of dignity and provides the theoretical base for a ther-
apeutic intervention: dignity therapy[4].
Dignity Therapy is a brief, individualized intervention to
increase the sense of purpose, meaning and worth and
reduce spiritual and psychological suffering for people
with advanced cancer. The therapy can be delivered at the
bedside by health care professionals (after brief training).
The therapist conducts an interview, which is based on the
dignity model[2]. Individuals are offered the opportunity
to address aspects of life they feel most important, such as
recounting parts of their life they feel proudest of, things
they feel are or were most meaningful, the personal his-
tory they would most want remembered, or advice to their
family and friends. Interviews last between 30 and 60
minutes. They are tape recorded, transcribed, edited, (see
methods for details of editing procedure) and quickly
returned to the patient to share with people of their
choosing. These 'generativity' documents allow people to
leave behind something lasting. An important feature of
the therapy is that it also has the potential to help friends
and relatives in their bereavement[5].
A preliminary evaluation of Dignity Therapy conducted
with patients with advanced cancer in Canada and Aus-
tralia have produced positive findings for patients[4] and
their families[5]. Ninety-one percent of participants
reported being satisfied with dignity therapy; 76%
reported a heightened sense of dignity; 68% reported an
increased sense of purpose; 67% reported a heightened
sense of meaning; 47% reported an increased will to live;
and 81% reported that it had been, or would be of help to
their family. Randomised controlled trials (RCTs) of Dig-
nity Therapy for hospice patients are underway in Canada,
Australia and the USA, assessing outcomes immediately
after the intervention. However, the longer term impact of
the intervention on patients is not being assessed. Further-
more, since responses to Dignity Therapy may be influ-
enced by a range of important social and cultural factors,
the results of these trials may not be generalisable to the
UK. There are a number of potential moderators of the
impact of intervention (e.g. ethnicity, age, cognitive acu-
ity, stage of illness, baseline levels of distress). Answering
these questions would require a randomised controlled
trial in the UK. There are a number of methodological and
ethical issues concerning conducting RCTs of patients
with advanced cancer[6], including concerns about ran-
domisation, loss to follow-up and appropriate user
involvement in the research.
In-depth piloting, which includes an exploration of the
feasibility of delivering an intervention and attention to
the context in which interventions take place, as planned
here, is recommended in the new Medical Research guid-
ance for developing and evaluating complex interven-
tions[7]. As recommended in the MRC framework, we are
also testing our proposed outcome measures. The results
will inform the design of a Phase III RCT.
Aims and objectives
The aims of the study are to assess the feasibility, accepta-
bility and potential effectiveness of Dignity Therapy to
reduce psychological and spiritual distress in people with
advanced cancer who have been referred to hospital-based
palliative care teams. The specific objectives are to:
a) Determine whether Dignity Therapy is likely to increase
peoples' sense of dignity or reduce psychological or spirit-
ual distress.
b) Determine whether it is feasible to provide Dignity
Therapy in this setting.
c) Determine whether Dignity Therapy is acceptable to
patients and their families.
d) Pilot methods for a larger (Phase III) RCT (e.g. recruit-




A Phase II open-label RCT comprising two groups: (i)
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sional palliative care team, including nurses, a psychoso-
cial worker and doctors trained in providing psychosocial
support. Consenting participants have been randomly
allocated to one of these two groups after baseline (T1)
measures have been collected.
Randomization
Randomization was conducted by an independent statis-
tician. Treatment allocation (Dignity Therapy or control)
was performed by block randomization with a fixed block
size of two. Allocation concealment is facilitated by using
sequentially numbered opaque sealed envelopes for con-
secutive and eligible participants. To reduce the risk of
bias, the research assistant opens the next envelope in the
presence of the patient to ascertain which group the
patient has been allocated to after baseline measures have
been collected from participants.
Ethical Approval
This study has been approved by The King's College Hos-
pital Research Ethics Committee (10/11/2008, ref: 08/
H0808/155), and meets the requirements of the local
Research Governance Framework.
Participants
The sample will comprise 40 adults with advanced cancer
who have been referred to hospital-based palliative care
teams working in two NHS Trusts, and who are well
enough to participate in a protocol lasting two weeks. For
this pilot study, we are obtaining in-depth information on
taking part in the study and receiving the therapy from a
relatively small sample rather than planning to detect sig-
nificant group differences. One of the aims of the study is
to estimate the effect size for an RCT.
Inclusion criteria
Patients with a diagnosis of cancer aged 18 years or over
are included. We are not selecting people on the basis of
prognosis or stage of disease, however, since patients are
receiving palliative care, most are expected to have
advanced cancer. Participants are not screened for spirit-
ual or psychological distress, or loss of dignity, however,
these are assessed at baseline to explore the potential
moderating effects of these variables on the impact of the
intervention.
Exclusion criteria
Patients are excluded if the palliative care team feel they
are unable to take part in a protocol lasting two weeks (the
time taken to collect baseline measures and complete the
intervention), or if they are unable to provide informed
consent either due to cognitive problems or the severity of
their illness, or because they are unable to understand
English. Patients with moderate or severe cognitive
impairment are excluded since their 'generativity' docu-
ments are likely to reflect a fractured sense of self, which
could be distressing to them and recipients of these docu-
ments.
A close family member or friend (for participants in both
groups) is invited into the study to obtain their views on
taking part in the study and the therapy (intervention
group only). These are usually the recipients of the 'gener-
ativity' documents, however, any additional recipients
will also be invited to take part to obtain their views on
the therapy.
The intervention
The therapy is delivered by a palliative care nurse who has
been trained in Dignity Therapy by Harvey Chochinov
(who developed it). Training included the theoretical
basis for the intervention, demonstrations of Dignity
Therapy, a detailed overview of the therapy manual, edit-
ing the therapy documents and working with patients to
produce a document that will be helpful for them and its
recipients.
A standard framework of questions used in the therapy
(Appendix 1) is given to patients in the intervention group
(after randomization) to give them the opportunity to
think about their responses before the session. The ques-
tion framework provides a flexible guide for the therapist
to shape the interview, based on patients' level of interest
and responses. The therapist follows the patients' cues,
helping them to structure and organise their thoughts, for
example, by asking questions about time sequences, how
events are causally related to each other and facilitating
the disclosure of thoughts, feelings and memories. If a
patient prefers a friend or relative to be present during the
dignity therapy session, they can either listen or join in.
Patients sometimes find they need help to recall details.
This strategy has proved to be very helpful for some
patients in the piloting of Dignity Therapy in Canada,
Australia & USA. The role of the person sitting in will be
agreed with the patient beforehand, and the therapist will
ensure that the discussion is led by the patients rather
than their friends or relatives.
These interviews are tape-recorded, quickly transcribed
verbatim then shaped into a narrative using a formatted
editing process. This includes clarifications to eliminate
colloquialisms, non-starters and irrelevant sections (such
as interruptions), chronological corrections, tagging and
editing any content that might inflict significant harm on
recipients of the document (after discussion with the
patient) and finding a suitable ending for the document
which is appropriate to the patients' overall message.
Another session is arranged for the therapist to read the
edited transcript to the participants, who are invited toPage 3 of 8
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errors of omission or commission. Once these 'generativ-
ity' documents are finalised they become the property of
the patient, who can share it with anyone they choose,
whenever they choose. We give them as many copies as
they wish. At the start of the therapy, we ask patients who
they intend to leave the 'generativity' document to, as this
enables the therapist to guide the patient to cover the
areas most relevant to the intended recipient(s). However,
patients can change their mind about this at any time.
They may decide not to give their 'generativity' document
to anyone, or give it to other recipients. We do not exclude
patients who do not wish to pass on their document. If
they do not wish to bequeath it to anyone they can either
destroy it or leave it with their other personal documents
such as their will, diaries and important letters. The thera-
pist discusses this with any patients who decide not to
bequeath their document.
Since participants' conditions can fluctuate rapidly, the
timing of the contacts can be relaxed and meetings
rescheduled. If a participant's condition deteriorates,
meetings are rescheduled up to three times before sensi-
tively withdrawing them from the study. The therapist
makes detailed notes of her experiences of giving each
intervention and any deviations from the protocol. One
in three therapy transcripts is randomly selected for review
by the principal investigators. A quality assurance proto-
col has been developed to assess adherence to the Dignity
Therapy protocol and deviations from the protocol will be
reported as part of the feasibility study. This includes
whether or not the therapist was respectful and asked the
questions from the Dignity Therapy protocol appropri-
ately, and whether or not the editing process was carried
out in accordance to the protocol.
Control group
Patients in the control group have at least three interviews
with a research assistant. Completing the measures and
taking part in the interview gives them an opportunity to
talk about their feelings. The extent to which they feel that
this is therapeutic is explored in the follow-up interviews.
Recruitment procedure
The recruitment and follow-up procedure is shown in Fig-
ure 1. Potential participants are identified by palliative
care teams from their lists. For patients recruited from one
NHS Trust, these are in-patients or those visiting out-
patient clinics. The research assistant gives potential par-
ticipants an invitation letter and patient information sheet
after being introduced by the palliative care team. The
research assistant visits patients at least 24 hours later to
find out if they are interested in taking part. From the
other Trust we are recruiting patients cared for in the com-
munity. The clinical nurse specialist visiting the patient
will give them the invitation letter and patient informa-
tion sheet. They will be asked to send a reply slip to the
research team or to notify the Clinical Nurse Specialist of
their decision to take part or not. Patients are encouraged
to discuss involvement in the study with family or friends
before deciding whether or not to take part.
Before consent is taken from patients who have expressed
an interest in taking part, the research assistant checks
they have fully understood the patient information sheet
before obtaining written consent from those who are will-
ing to take part. As a final check patients are screened with
the Blessed Orientation Memory Concentration Test [8]
to assess cognitive functioning after the consent proce-
dure. It has been suggested by Chochinov (personal com-
munication) that Dignity Therapy is not suitable for
patients with a score equal to or greater than 15. In such
cases patients are excluded. This is done sensitively: the
research assistant spends some time chatting with them
about neutral topics. This approach has worked success-
fully in a previous study[9]. The proportion of patients
excluded at this stage will be reported. Oncologists in the
Trusts have been informed of the study and General Prac-
titioners will be informed of their patients' involvement.
Following the consent procedure, participants are asked to
complete the baseline measures. They are then rand-
omized. Those in the intervention group are given the
framework of therapy questions (Appendix 1) so that they
have an opportunity to think about their answers before
the therapy interview. The therapist arranges to conduct
the dignity therapy interview as soon as possible after
recruitment (usually within two to three days), in the
location most suited to the patient and in the most private
area available if they are in hospital. Since the condition
of participants could fluctuate rapidly, the timing of the
contacts are sometimes adjusted and meetings resched-
uled. If a participant's condition deteriorates, meetings are
rescheduled up to three times before sensitively excusing
them from the study. This, and the feasibility of following
up with people if they leave hospital, will also be reported
and taken into account when developing the RCT. Partic-
ipants in the control group are reminded that they will
still have the opportunity to talk to the researcher about
how they are feeling and about their views on taking part
in the study.
At recruitment the research assistant asks participants to
nominate a close family member or friend who is invited
to take part in a telephone interview. For patients in the
intervention group the nominated family member or
friend is often the recipient of the 'generativity' document,
however, if the participant mentions other recipients they
will also be invited for interview. Participants are not
excluded if they do not nominate a family member orPage 4 of 8
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Recruitment and follow-up procedureFigure 1
Recruitment and follow-up procedure.
After group allocation
Patients Identified by Palliative Care Team 
Research assistant invites the patients into the study (invitation letters and information sheets given to patients eligible for study) 
Given at least 24 hours to consider 
Intervention n = 20
(Dignity therapy + standard care)
Control n = 20
(Standard care) 
For patients who express 
interest in taking part 
1. Explain study 
2. Obtain informed consent 
4. T1 (baseline) interview 
5. Group allocation  
6. Obtain consent to contact 
family of control group 
Dignity therapy questions given to 
patient by research assistant  
Within 1-2 days after T1 
1. Dignity therapy delivered by therapist
2. Patient asked who they wish to 
    bequeath document to 
3. Obtain consent to contact family 
     members/friend or recipient 
Within 2-4 days 
1. Dignity therapy interview transcribed & 
    edited by the therapist   
2. Review of “generativity” document with
    patient. Final document given to patient 
As soon as possible after dignity therapy  
T2 follow-up 
interview
4 weeks after dignity therapy 
T3 follow-up 
interview
Within 7 days after T1
T2 follow-up interview 
Within 4 weeks of T1 
T3 follow-up interview 
FAMILY (Control) 
Sent information sheet/reply 
Slips/Consent form 
Family of control: Interview 
1 after patient completes T1 
interview  
Family intervention:
Interview 1 as soon as 
possible after intervention  
Interview two 3 months post 
bereavement for all family 
members of both groups  
BMC Palliative Care 2009, 8:5 http://www.biomedcentral.com/1472-684X/8/5friend. We contact the palliative care teams to determine
when a participant has died and conduct interviews three
months post bereavement with all nominated family and
friends and any additional recipients of the document.
Outcomes
Both quantitative and qualitative outcomes are assessed
(Table 1). These are collected from patients by face-to-face
interviews at two time-points: approximately one (T2)
and four weeks (T 3) after the dignity document has been
completed, and the equivalent in the control group. This
longer-term follow-up has not been included in the previ-
ous evaluation of Dignity Therapy, or in the current trials
being conducted by Chochinov and colleagues. However,
we believe it is important to evaluate the longer-term
impact of the intervention. The feasibility of doing this is
explored as part of this feasibility study. Quantitative
measures have been validated and are fairly quick and
easy to use. Qualitative interview schedules have been
developed for the study.
Main outcome for patients
The primary outcome is patients' sense of dignity (poten-
tial effectiveness). This is assessed at baseline, (T1) and at
T2 and T3 follow-ups, using the Patient Dignity Inven-
tory[10]. This measure evolved directly from the dignity
model, therefore, questions correspond to each of the
model themes and sub-themes, including: physical, psy-
chosocial, existential and spiritual domains of concern or
distress. This measure has been validated in Canada and
has been shown to have excellent face, internal, test-retest
and concurrent validity.
Secondary outcomes for patients
Potential effectiveness is also assessed using: the Hospital
Anxiety and Depression scale[11] and the distress ther-
Table 1: Measures for each time point
Patients Family/friends
Intervention Control Intervention Control
At patient recruitment
Patient characteristics x x
Patient Dignity Inventory10 x x
Herth Hope Index13 x x
Hospital Anxiety & Depression Scale11 x x
Distress Thermometer12 x x
EQ-5D14 (Quality of life) x x
Two item measure of quality of Life x x
Palliative Care Outcome Scale15 x x
As soon as possible post intervention
Acceptability of therapy/study
(interviews)
x x x x
Patient Dignity Inventory10 x x
Herth Hope Index13 x x
Hospital Anxiety & Depression Scale11 x x
Distress Thermometer12 x x
EQ-5D14 (Quality of life) x x
Two item measure of quality of Life x x
Palliative Care Outcome Scale15 x x
One month post intervention
Acceptability of therapy/study x x
Patient Dignity Inventory10 x x
Herth Hope Index13 x x
Hospital Anxiety & Depression Scale11 x x
Distress Thermometer12 x x
EQ-5D14 (Quality of life) x x
Two item measure of quality of Life x x
Palliative Care Outcome Scale15 x x
Three months post bereavement*
Hospital Anxiety & Depression Scale11 x x
Complicated Grief assessment20 x x
Acceptability of therapy/study x x
Palliative Care Outcome Scale15 x x
* It is likely that it will not be possible to collect post bereavement outcomes from all the recipients of the legacy documents within the relatively 
short timeframe of this pilot study. However, in depth qualitative data on their views of the therapy, taking part in the study and completing the 
outcome measures will be obtained from those who are interviewed.Page 6 of 8
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Index[13] (hopefulness); the EQ-5D[14], the POS (Pallia-
tive Care Outcomes) [15] and a two item measure used by
Harvey Chochinov in the current trials of Dignity Therapy
(both quality of life). To assess feasibility of delivering
Dignity Therapy in this setting, time taken to organize and
conduct the Dignity Therapy sessions, transcribe and edit
narratives, deviations from the therapy protocol and
uncompleted interventions and the reasons, and the ther-
apist's perceptions of competence as a result of training
are recorded. To assess the acceptability of Dignity Ther-
apy we are conducting semi-structured interviews with
participants in the intervention group to obtain their
views on the intervention. The therapist is recording her
experiences of delivering the therapy and her observations
of patient's responses during and after the therapy. As sug-
gested by Ferrell[16], we are reporting case studies of any
difficult cases.
Demographic measures
Demographic information is collected, including: cogni-
tive functioning (using the Blessed Orientation Memory
Concentration test[8]), co-morbidity (using the Comor-
bidity Index and Scores of Charlson[17]), performance
status (using Karnosfsky scores[18], and ability to perform
activities of daily living (Barthel scores[19]), age, gender,
ethnic group.
Outcome measures for family/friends/recipients of 'generativity' 
documents
In completion of the therapy, semi-structured telephone
interviews are conducted with patients' family/friends and
other recipients of the 'generativity' documents to obtain
their perceptions of the impact of the intervention, on
themselves and on the patient (intervention group), and
their views on taking part in the study (both groups). For
patients who die during the data collection period of the
study, follow-up telephone interviews are conducted with
family/friends/recipients of the 'generativity' documents
at three months post bereavement. As in the initial inter-
view, these cover their perceptions of the impact of the
intervention, on themselves and on the patient, and their
views on taking part in the study. They are also asked to
complete the Complicated Grief Assessment[20], which is
used to screen for complicated grief reactions and the
Hospital Anxiety and Depression Scale [11]. The ques-
tionnaire is mailed to them after the telephone interview
along with a pre-paid envelope in which to return it. Their
age, gender, ethnic group and relationship to patients are
also recorded.
Piloting methods for a Phase III trial
Time taken to obtain informed consent and collect out-
comes, exclusions, recruitment and drop-out rates
(patients and their family and friends) are recorded. In
addition their views on taking part in the study (e.g. being
randomized) are sought in qualitative interviews, and
their views on completing the outcome measures are
recorded when they are completing them. Any problems




In view of the relatively small sample size, analyses will be
mainly descriptive, however, between and within partici-
pant comparisons of outcomes will be conducted and the
appropriate effect size estimates reported. Either paramet-
ric or non-parametric tests will be used, depending on the
distribution of the data. The intervention and control
group will be compared on the main outcome (a sense of
dignity) and secondary outcomes (distress, hopefulness,
quality of life and palliative care outcomes). We will also
compare Time 2 and Time 3 follow-up with baseline for
both groups on these measures, using a paired test. The
two groups will also be compared on demographic char-
acteristics and baseline measures. We will also report
recruitment rates and compare drop-out rates and missing
data in the two groups.
Qualitative data
We are using the Framework method of analysis [21].
Analyses are both deductive (from pre-set aims and objec-
tives) and inductive (arising from participants views). This
method tends to be more structured than some other
methods of qualitative analysis and the process more
explicit and more informed by a priori questions. It is
designed so that it can be more easily understood and
assessed by people other than the analyst, such as funding
bodies, policy makers and participants. Throughout the
analytical process we use strategies to maximise credibil-
ity, criticality, and authenticity[22]. The QSR NVivo soft-
ware package is used to manage the qualitative data.
Discussion
There is a dearth of interventions to reduce psychological
and spiritual distress for people with advanced cancer.
Dignity Therapy is brief, can be done at the bedside and
aims to help both patients and their families. The pro-
posed detailed exploratory research will show if it is feasi-
ble to offer Dignity Therapy to patients with advanced
cancer who have been referred to hospital-based palliative
care teams, whether it is acceptable to them and their fam-
ilies, if it is likely to be effective, and determine whether a
Phase III RCT is needed. As suggested by Ferrell [16], we
plan to report the therapists experiences of delivering the
therapy, any difficult cases and how they dealt with them,
for example those who had intense regrets about their
lives or difficult conflicts to resolve. If the trial shows Dig-
nity Therapy is effective, it could prove to be a relativelyPage 7 of 8
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Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SH led the drafting of this paper and development of the
protocol. HC developed Dignity Therapy. SH & IJH co-
conceived the study. All authors co-applied for funding
and contributed to the development of the protocol and
the final draft of this paper.
Appendix 1 framework of questions used in 
Dignity Therapy
• Tell me a little about your life history; particularly the
parts that you either remember most, or think are the
most important? Another way of putting this, which may
elicit answers from some patients, is to ask, when did you
feel most alive?
• Are their particular things that you would want your
family to know about you, and are their particular things
you would want them to remember?
• What are the most important roles you have played in
your life (family roles, vocational roles, community serv-
ice roles, etc)? Why were they so important to you, and
what do you think you accomplished within those roles?
• What are your most important accomplishments, and
what do you feel most proud of?
• Are there particular things that you feel still need to be
said to your loved ones, or things that you would want to
take the time to say once again?
• What are your hopes and dreams for your loved ones?
• What have you learned about life that you would want
to pass along to others? What advise or words of guidance
would you wish to pass along to your [son, daughter, hus-
band, wife, parents, other(s)]?
• Are their words or perhaps even instructions you would
like to offer your family, in order to provide them with
comfort or solace?
• In creating this permanent record, are their other things
that you would like included?
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